UDP-N-acetyl-D-galactosamine disodium salt
1 Inquiries
108320-87-2
95%
2026-06-30
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
ProductName UDP-N-acetyl-D-galactosamine disodium salt Cat No COEC-016 Description UDP-N-acetyl-D-galactosamine disodium salt is a donor substrate for N-acetylgalactosaminyltransferases. The compound is a major terminal sugar of the cyst wall of Giardia lamblia. UDP-N-acetyl-D-galactosamine is useful in the synthesis of aryl azide derivatives that can be employed in affinity labeling of glycosyltransferases and UDP-HexNAc pyrophosphorylase. Applications A donor substrate for N-acetylgalactosaminyltransferases Appearance Crystalline powder Form Solid CAS No 108320-87-2 Molecular Weight 651.32 Purity ≥95% Synonyms UDP-N-acetylgalactosamine Molecular Formula C17H25N3Na2O17P2 Solubility Soluble in water (50 mg/ml). Refractive Index 1.47 Density 1.4 g/cm3 at 20° C category Saccharides(c1518) cas_num 108320-87-2 Basic Info-
Product Name:
UDP-ALPHA-D-N-ACETYLGALACTOSAMINE, DISODIUM SALT
Other Name:UDP-GALNAC, 2NA;UDP-ALPHA-D-N-ACETYLGALACTOSAMINE, DISODIUM SALT;URIDINE-DIPHOSPHATE-N-ACETYLGALACTOSAMINE DISODIUM SALT;URIDINE[5']DIPHOSPHO[1](2-ACETAMINO-2-DEOXY-ALPHA-D-GALACTOPYRANOSE) DISODIUM SALT;URIDINE 5'-DIPHOSPHO-N-ACETYLGALACTOSAMINE DISODIUM SALT;UDP-a-D-N-Acetylgalactosamine,Disodium Salt;uridine 5-diphospho-N-*acetylgalactosamine disod;URIDINE-5'-DIPHOSPHO-N-ACETYL-GALACTOS-&
CAS No.:108320-87-2
Molecular Formula:C17H25N3Na2O17P2
InChIKeys:HXWKMJZFIJNGES-QCVFHWOISA-L
Molecular Weight:651.32
Exact Mass:651.04500
DSSTox ID:DTXSID40585285
HScode:29349990
Categories:
Characteristics-
PSA:
331.14000
Water Solubility:H2O: 50 mg/mL, clear, colorless
Storage Conditions:−20°C
Collision Cross Section:228.4 Ų [M-2H+Na]-
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Sweden
UDP-GalNAc disodium salt
700 MG Mar 10, 2026 Post an enquiry for this product